These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1379839)

  • 1. Distribution kinetics of FK-506, a novel immunosuppressant, after intravenous administration to rats in comparison with cyclosporin A.
    Takada K; Usuda H; Oh-Hashi M
    Biopharm Drug Dispos; 1992 Jul; 13(5):345-55. PubMed ID: 1379839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution characteristics of immunosuppressants FK506 and cyclosporin A in the blood compartment.
    Takada K; Katayama N; Kiriyama A; Usuda H
    Biopharm Drug Dispos; 1993 Nov; 14(8):659-71. PubMed ID: 7508273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.
    Takada K; Usuda H; Oh-Hashi M; Yoshikawa H; Muranishi S; Tanaka H
    J Pharmacobiodyn; 1991 Jan; 14(1):34-42. PubMed ID: 1713626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of co-administration of Intralipid on the pharmacokinetics of cyclosporine in the rabbit.
    Shah AK; Sawchuk RJ
    Biopharm Drug Dispos; 1991; 12(6):457-66. PubMed ID: 1932609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
    Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.
    Jin M; Shimada T; Yokogawa K; Nomura M; Mizuhara Y; Furukawa H; Ishizaki J; Miyamoto K
    Int J Pharm; 2005 Apr; 293(1-2):137-44. PubMed ID: 15778051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose.
    Molpeceres J; Chacón M; Guzmán M; Aberturas MR; Berges L
    Int J Pharm; 2000 Mar; 197(1-2):129-41. PubMed ID: 10704800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid.
    Hibbins M; Inutsuka S; Chapman JR
    Transpl Immunol; 1993; 1(1):66-71. PubMed ID: 7521736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506.
    Mor E; Patel T; Glabman S; Sheiner P; Emre S; Guy S; Schwartz M; Miller C
    Transpl Int; 1994; 7 Suppl 1():S77-80. PubMed ID: 11271340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
    Ahmed SS; Strobel HW; Napoli KL; Grevel J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1047-54. PubMed ID: 7685382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from cyclosporin to FK 506 after liver transplantation.
    Winkler M; Ringe B; Jost U; Melter M; Rodeck B; Buhr T; Brinkmann C; Pichlmayr R
    Transpl Int; 1993; 6(6):319-24. PubMed ID: 7507677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats.
    Yano K; Fukuda Y; Sumimoto R; Ito H; Sumimoto K; Dohi K
    Transpl Int; 1994; 7 Suppl 1():S187-93. PubMed ID: 11271200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results.
    Pham SM; Kormos RL; Hattler BG; Kawai A; Tsamandas AC; Demetris AJ; Murali S; Fricker FJ; Chang HC; Jain AB; Starzl TE; Hardesty RL; Griffith BP
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):764-72. PubMed ID: 8614136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
    Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
    J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
    Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K
    Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
    Cakaloglu Y; Tredger JM; Devlin J; Williams R
    Hepatology; 1994 Aug; 20(2):309-16. PubMed ID: 7519161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
    Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
    Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?
    Dmitrewski J; Ayres S; Gunson BK; Buist LJ; Buckels JA; McMaster P; Mayer AD
    Transpl Int; 1994; 7 Suppl 1():S85-7. PubMed ID: 11271342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.